Suraksha Diagnostic Ltd
Ticker: SURAKSHA
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
317.95
Market Cap
1655.91
Debt/Equity
0.4228
ROE %
16.354
PB
7.8766
Promoter %
48.982
Pledge %
0.000
1Y Rev Growth %
15.153
5Y Rev Growth %
9.983
NP Margin %
12.440
NP Margin 5Y Avg %
8.307
Trading Reference
1M Return %
8.277
6M Return %
6.480
1Y Return %
-23.799
% Away 52W High
41.217
% Away 52W Low
37.641
Daily Volume
13536
Investment Verdict
Risky
Score 55/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 41/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Suraksha Diagnostic Ltd shows potential for growth in the expanding healthcare sector, but faces competitive pressures.
✅ Positives
- Strong demand for diagnostic services
- Expanding network of diagnostic centers
- Innovative technology adoption
⚠️ Negatives
- Intense competition in the market
- Regulatory challenges in healthcare
- High operational costs
Verdict
Cautiously optimistic about future performance.
Recommendation: Consider buying on dips.
Upside Probability: 25% | Downside Probability: 15%
Last generated: 31/10/2025
More Options
C
Centrum Capital Ltd
Centrum Capital Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised.
View details
H
Himatsingka Seide Ltd
Himatsingka Seide Ltd shows potential in a competitive sector, but faces challenges in profitability and execution risks.
View details
S
Shanti Gold International Ltd
The stock presents several risks with inconsistent growth and weak market sentiment, making it a risky investment.
View details
B
Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd shows potential but faces challenges in profitability and execution risks. Investors should proceed with caution.
View details
D
Dolphin Offshore Enterprises (India) Ltd
Dolphin Offshore Enterprises shows potential in a future-ready sector but faces significant risks in growth and profitability, making it a risky investment at this time.
View details
G
G M Breweries Ltd
G M Breweries Ltd shows moderate potential but faces several challenges that could impact future performance.
View details
R
Rama Steel Tubes Ltd
Rama Steel Tubes Ltd shows potential but faces challenges in growth consistency and profitability metrics.
View details
J
Jagsonpal Pharmaceuticals Ltd
Jagsonpal Pharmaceuticals Ltd shows potential but faces significant challenges in profitability and valuation metrics. Caution is advised for investors.
View details
A
Asian Energy Services Ltd
Asian Energy Services Ltd shows potential in a future-ready sector but faces challenges in growth consistency and valuation metrics.
View details
A
Andhra Paper Ltd
Andhra Paper Ltd shows potential but faces challenges in growth consistency and market competition.
View details
R
Roto Pumps Ltd
Roto Pumps Ltd shows several weaknesses in growth, profitability, and market sentiment, indicating a risky investment.
View details
S
Shriram Properties Ltd
While Shriram Properties Ltd has potential in a growing sector, inconsistencies in financial performance and valuation concerns warrant caution.
View details
M
MM Forgings Ltd
MM Forgings Ltd shows a decent investment potential with consistent growth and profitability metrics, but some risks in governance and execution should be monitored.
View details
D
DAM Capital Advisors Ltd
DAM Capital Advisors Ltd shows a decent investment potential with a solid business model and consistent growth, but attention should be paid to liquidity and execution risks.
View details
J
Jagran Prakashan Ltd
Jagran Prakashan Ltd shows potential in a transitioning media landscape but faces challenges in growth consistency and valuation metrics.
View details
E
Everest Kanto Cylinder Ltd
The stock presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns. Caution is advised.
View details
Business Overview
Suraksha Diagnostic Ltd is a leading healthcare provider in India, specializing in diagnostic services. Catering to individuals, families, and healthcare professionals, Suraksha aims to deliver accurate and timely test results to enhance patient care. With a commitment to quality and reliability, it plays a crucial role in early disease detection and management. Suraksha's state-of-the-art technology and experienced team ensure that you receive the best diagnostic services available, making it an essential choice for your health needs.
- Leading provider of diagnostic services in India
- Focus on accuracy and timely results
- Supports early disease detection and management
- State-of-the-art technology and experienced professionals
- Committed to enhancing patient care and health outcomes
Investment Thesis
Suraksha Diagnostic Ltd stands out due to its credible promoter group, robust growth in digital services, and attractive valuation compared to peers. This combination positions the company for sustainable growth and offers a compelling investment opportunity for retail investors.
- Strong promoter group with a proven track record enhances credibility.
- Significant growth potential in digital diagnostics services.
- Attractive valuation metrics compared to industry peers.
- Expanding market presence in a growing healthcare sector.
- Focus on innovation and technology to drive future growth.
Opportunity vs Risk
Opportunities
- Growing demand for health diagnostics
- Expansion into tier-2 cities
- Partnerships with hospitals
- Technological advancements in testing
- Increased health awareness post-pandemic
Risks ⚠️
- Regulatory changes in healthcare
- Intense competition in diagnostics
- Economic downturn affecting consumer spending
- Dependence on a few key markets
- Potential data privacy issues
Peer Perspective
Suraksha Diagnostic Ltd trades at a discount to peers like Dr. Lal PathLabs and Thyrocare, primarily due to margin pressures. A stabilization in margins could trigger a rerating, aligning its valuation with industry standards.
Future Outlook
Suraksha Diagnostic Ltd is poised for growth as it expands its service offerings and enhances operational efficiency. Successful execution of its strategic initiatives and effective cost control will be key to unlocking its full potential.
AI FAQs for Retail Users
- Q: What does Suraksha Diagnostic Ltd do?A: Suraksha Diagnostic Ltd provides diagnostic and healthcare services across various locations in India.
- Q: Is Suraksha Diagnostic Ltd a profitable company?A: The company has reported profits in recent quarters, but past performance does not guarantee future results.
- Q: What are the risks of investing in Suraksha Diagnostic Ltd?A: Risks include market competition, regulatory changes, and economic factors affecting healthcare services.
- Q: How can I buy shares of Suraksha Diagnostic Ltd?A: You can buy shares through a registered broker or an online trading platform.
- Q: What should I consider before investing in Suraksha Diagnostic Ltd?A: Consider the company's financial health, market position, and your own investment goals.
📊 Stock Investment Checklist (100 Points)
Suraksha Diagnostic Ltd • Updated: 2025-09-18 01:13:47
-
10BusinessHighThe diagnostics sector is growing, but competition is increasing.
-
10GrowthHighRevenue growth has been consistent, but profit margins are under pressure.
-
10ProfitabilityHighROE is decent, but OCF is fluctuating.
-
8ValuationHighValuation metrics are above industry averages.
-
7BalanceHighModerate debt levels, but liquidity is adequate.
-
6GovernanceGoodPromoter holding is stable, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Suraksha Diagnostic Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 60/100
- Market Confidence: 68/100